Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

ABSTRACT:

Background

The Centers for Medicare and Medicaid Services (CMS) considered whether to reimburse computed tomographic colonography (CTC) for colorectal cancer screening of Medicare enrollees. To help inform its decision, we evaluated the reimbursement rate at which CTC screening could be cost-effective compared with the colorectal cancer screening tests that are currently reimbursed by CMS and are included in most colorectal cancer screening guidelines, namely annual fecal occult blood test (FOBT), flexible sigmoidoscopy every 5 years, flexible sigmoidoscopy every 5 years in conjunction with annual FOBT, and colonoscopy every 10 years.

Methods

We used three independently developed microsimulation models to assess the health outcomes and costs associated with CTC screening and

SUBMITTER: Knudsen AB 

PROVIDER: S-EPMC2923219 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature